Treatment of active steroid-refractory inflammatory bowel diseases with granulocytapheresis: Our experience with a prospective study

World Journal of Gastroenterology

Volumn 12, Issue 14, 2006, Pages 2201-2204

  Giampaolo, Bresci ^a,b   Giuseppe, Parisi ^a   Michele, Bertoni ^a   Alessandro, Mazzoni ^a   Fabrizio, Scatena ^a   Alfonso, Capria ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b NONE   (Italy)

Author keywords

Crohn's disease; Granulocytapheresis; Steroid refractory; Ulcerative colitis

Indexed keywords

CORTICOSTEROID DERIVATIVE; MESALAZINE; METHYLPREDNISOLONE;

ADSORPTION CHROMATOGRAPHY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; CYTAPHERESIS; DISEASE ACTIVITY; DISEASE DURATION; DRUG EFFICACY; ENDOSCOPY; ENTERITIS; EXPERIENCE; FEMALE; GRANULOCYTE; HEADACHE; HUMAN; MALE; MEDICAL INSTRUMENTATION; MONOCYTE; PROSPECTIVE STUDY; REMISSION; SYMPTOMATOLOGY; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 33646238228     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i14.2201     Document Type: Article

References (17)

1. Sloan WP Jr, Bargen JA, Gage RP. Life histories of patients with chronic ulcerative colitis: a review of 2,000 cases. Gastroenterology 1950; 16: 25-38
2. Mekhjian HS, Switz DM, Mehiyk CS, Rankin GB, Brooks RK. Clinical features and natural history of Crohn's disease. Gastroenterology 1979; 77: 898-906
3. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985; 88: 1818-1825
4. Bresci G, Parisi G, Gambardella L, Band S, Bertoni M, Rindi G, Capria A. Evaluation of clinical patterns in ulcerative colitis: a long-term follow-up. Int J Clin Pharmacol Res 1997; 17: 17-22
5. Bresci G, Parisi G, Bertoni M, Capria A. Long-term maintenance treatment in ulcerative colitis: a 10-year follow-up. Dig Liver Dis 2002; 34: 419-423
6. Summers RW, Switz DM, Sessions JT Jr, Becktel JM, Best WR, Kern F Jr, Singleton JW. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847-869
7. Riis P, Anthonisen P, Wulff HR, Folkenborg O, Bonnevie O, Binder V. The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year. Scand J Gastroenterol 1973; 8: 71-74
8. Ardizzone S, Petrillo M, Imbesi V, Cerutti R, Bollani S, Bianchi Porro G. Is maintenance therapy always necessary for patients with ulcerative colitis in remission? Aliment Pharmacol Ther 1999; 13: 373-379
9. Yamaji K, Fukunaga K, Yamane S, Sueoka A, Nose Y. Current therapeutic apheresis technologies for inflammatory bowel disease. Ther Apher 1998; 2: 105-108
10. Kawamura A, Saitoh M, Yonekawa M, Horie T, Ohizumi H, Tamaki T, Kukita K, Meguro J. New technique of leukocytapheresis by the use of nonwoven polyester fiber filter for inflammatory bowel disease. Ther Apher 1999; 3: 334-337
11. Kohgo Y, Ashida T, Maemoto A, Ayabe T. Leukocytapheresis for treatment of IBD. J Gastroenterol 2003; 38 Suppl 15: 51-54
12. Kjeldsen J. Treatment of ulcerative colitis with high doses of oral prednisolone. The rate of remission, the need for surgery, and the effect of prolonging the treatment. Scand J Gastroenterol 1993; 28: 821-826
13. Kozarek R, Bedard C, Patterson D, Justus P, Sandford R, Greene M, Gelfand M, Bredfeldt J, Brentnall T, Putnam W. Cyclosporin use in the precolectomy chronic ulcerative colitis patient: a community experience and its relationship to prospective and controlled clinical trials. Pacific Northwest Gastroenterology Society. Am J Gastroenterol 1995; 90: 2093-2096
14. Su C, Lichtenstein GR. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine. Gastroenterol Clin North Am 2004; 33: 209-234, viii
15. Sawada K, Muto T, Shimoyama T, Satomi M, Sawada T, Nagawa H, Hiwatashi N, Asakura H, Hibi T. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 2003; 9: 307-321
16. Saniabadi AR, Hanai H, Takeuchi K, Umemura K, Nakashima M, Adachi T, Shima C, Bjarnason I, Lofberg R. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 2003; 7: 48-59
17. Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 2004; 49: 565-571